| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Inflammatory Bowel Diseases | 33 | 2025 | 304 | 11.420 |
Why?
|
| Crohn Disease | 40 | 2024 | 284 | 10.060 |
Why?
|
| Colitis, Ulcerative | 28 | 2023 | 205 | 9.120 |
Why?
|
| Colitis | 13 | 2024 | 153 | 5.390 |
Why?
|
| Clostridium Infections | 14 | 2023 | 245 | 4.890 |
Why?
|
| Intestinal Mucosa | 19 | 2022 | 779 | 4.020 |
Why?
|
| Microbiota | 11 | 2023 | 391 | 3.080 |
Why?
|
| Colon | 10 | 2024 | 352 | 2.920 |
Why?
|
| DNA Methylation | 19 | 2022 | 1002 | 2.840 |
Why?
|
| Feces | 15 | 2024 | 724 | 2.680 |
Why?
|
| Fecal Microbiota Transplantation | 14 | 2023 | 98 | 2.570 |
Why?
|
| Pemphigus, Benign Familial | 9 | 2015 | 11 | 2.110 |
Why?
|
| Epigenesis, Genetic | 13 | 2017 | 674 | 2.070 |
Why?
|
| Metagenome | 8 | 2013 | 149 | 2.050 |
Why?
|
| Gastrointestinal Microbiome | 7 | 2022 | 700 | 1.780 |
Why?
|
| Calcium-Transporting ATPases | 11 | 2007 | 55 | 1.710 |
Why?
|
| Colectomy | 5 | 2021 | 74 | 1.690 |
Why?
|
| Child | 68 | 2025 | 24361 | 1.610 |
Why?
|
| Biological Products | 2 | 2024 | 121 | 1.480 |
Why?
|
| Humans | 137 | 2025 | 124240 | 1.410 |
Why?
|
| BCG Vaccine | 2 | 2021 | 109 | 1.360 |
Why?
|
| Infliximab | 9 | 2022 | 67 | 1.320 |
Why?
|
| Genetic Predisposition to Disease | 15 | 2025 | 3150 | 1.210 |
Why?
|
| Granuloma | 3 | 2023 | 68 | 1.170 |
Why?
|
| Adolescent | 44 | 2025 | 19253 | 1.100 |
Why?
|
| Bacteria | 6 | 2019 | 484 | 1.050 |
Why?
|
| Gastrointestinal Tract | 4 | 2019 | 215 | 1.030 |
Why?
|
| Gastrointestinal Diseases | 2 | 2023 | 336 | 0.990 |
Why?
|
| Epigenomics | 5 | 2020 | 163 | 0.990 |
Why?
|
| RNA, Ribosomal, 16S | 9 | 2022 | 370 | 0.990 |
Why?
|
| Myosin Type V | 1 | 2025 | 9 | 0.950 |
Why?
|
| Male | 68 | 2025 | 61023 | 0.940 |
Why?
|
| Multifactorial Inheritance | 2 | 2025 | 138 | 0.930 |
Why?
|
| Cytomegalovirus Infections | 2 | 2022 | 218 | 0.920 |
Why?
|
| Enterocolitis, Pseudomembranous | 3 | 2019 | 93 | 0.870 |
Why?
|
| Cysts | 1 | 2024 | 101 | 0.860 |
Why?
|
| Female | 68 | 2025 | 66304 | 0.860 |
Why?
|
| Gastritis | 2 | 2019 | 371 | 0.840 |
Why?
|
| Phenotype | 13 | 2023 | 4251 | 0.810 |
Why?
|
| Prenatal Exposure Delayed Effects | 3 | 2018 | 225 | 0.790 |
Why?
|
| Diarrhea | 4 | 2016 | 317 | 0.770 |
Why?
|
| Enterocolitis | 1 | 2022 | 27 | 0.770 |
Why?
|
| Delayed Diagnosis | 2 | 2022 | 127 | 0.740 |
Why?
|
| Intestine, Small | 1 | 2024 | 312 | 0.740 |
Why?
|
| Gastrointestinal Agents | 4 | 2019 | 60 | 0.740 |
Why?
|
| Abnormalities, Multiple | 8 | 2008 | 956 | 0.730 |
Why?
|
| Saccharomyces cerevisiae | 8 | 2005 | 426 | 0.730 |
Why?
|
| Autoimmune Diseases | 1 | 2023 | 251 | 0.730 |
Why?
|
| Recurrence | 9 | 2023 | 1421 | 0.730 |
Why?
|
| Cholangitis, Sclerosing | 2 | 2018 | 59 | 0.720 |
Why?
|
| Anisakiasis | 1 | 2020 | 3 | 0.710 |
Why?
|
| Child, Preschool | 21 | 2025 | 13997 | 0.690 |
Why?
|
| Carbohydrates | 1 | 2020 | 34 | 0.690 |
Why?
|
| Dietary Supplements | 3 | 2013 | 476 | 0.680 |
Why?
|
| Ultrasonography | 2 | 2024 | 931 | 0.670 |
Why?
|
| Child Health | 1 | 2020 | 53 | 0.660 |
Why?
|
| Gastroenterology | 2 | 2019 | 196 | 0.660 |
Why?
|
| Intestines | 4 | 2020 | 575 | 0.640 |
Why?
|
| Granuloma, Giant Cell | 1 | 2019 | 13 | 0.640 |
Why?
|
| Educational Status | 1 | 2020 | 273 | 0.640 |
Why?
|
| Disease Susceptibility | 2 | 2011 | 298 | 0.620 |
Why?
|
| Bacteroides | 1 | 2019 | 34 | 0.610 |
Why?
|
| Gene Expression Regulation | 7 | 2019 | 2522 | 0.610 |
Why?
|
| Dietary Carbohydrates | 1 | 2019 | 119 | 0.610 |
Why?
|
| Academic Performance | 1 | 2018 | 18 | 0.610 |
Why?
|
| Vaccination | 2 | 2021 | 953 | 0.610 |
Why?
|
| Genome-Wide Association Study | 9 | 2022 | 1682 | 0.600 |
Why?
|
| Leukocyte L1 Antigen Complex | 1 | 2018 | 15 | 0.600 |
Why?
|
| Upper Gastrointestinal Tract | 1 | 2018 | 9 | 0.600 |
Why?
|
| Anti-Inflammatory Agents | 4 | 2014 | 283 | 0.590 |
Why?
|
| Age of Onset | 6 | 2025 | 586 | 0.590 |
Why?
|
| Diet | 5 | 2020 | 1133 | 0.580 |
Why?
|
| Genetic Variation | 2 | 2024 | 1493 | 0.570 |
Why?
|
| Seasons | 2 | 2018 | 309 | 0.560 |
Why?
|
| Colonic Polyps | 1 | 2018 | 78 | 0.560 |
Why?
|
| Immunocompromised Host | 1 | 2019 | 294 | 0.560 |
Why?
|
| Mice, Inbred C57BL | 9 | 2022 | 4401 | 0.550 |
Why?
|
| Antibodies, Monoclonal, Humanized | 2 | 2019 | 504 | 0.550 |
Why?
|
| Research Design | 1 | 2021 | 689 | 0.540 |
Why?
|
| Betacoronavirus | 1 | 2020 | 286 | 0.540 |
Why?
|
| Enteral Nutrition | 2 | 2019 | 255 | 0.540 |
Why?
|
| Purpura, Thrombocytopenic, Idiopathic | 1 | 2017 | 49 | 0.530 |
Why?
|
| Clinical Trials as Topic | 1 | 2021 | 1085 | 0.520 |
Why?
|
| Glucocorticoids | 1 | 2019 | 380 | 0.520 |
Why?
|
| Polymorphism, Single Nucleotide | 10 | 2025 | 2628 | 0.520 |
Why?
|
| Antibodies, Monoclonal | 5 | 2019 | 1017 | 0.510 |
Why?
|
| Magnesium Chloride | 1 | 2015 | 3 | 0.510 |
Why?
|
| Calcium | 7 | 2007 | 1099 | 0.500 |
Why?
|
| Gene Expression | 5 | 2021 | 1560 | 0.500 |
Why?
|
| Lipase | 1 | 2016 | 93 | 0.490 |
Why?
|
| Fatty Acids, Omega-6 | 1 | 2015 | 16 | 0.480 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 356 | 0.480 |
Why?
|
| Polymerase Chain Reaction | 2 | 2018 | 1585 | 0.480 |
Why?
|
| Mercaptopurine | 2 | 2014 | 71 | 0.480 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 370 | 0.480 |
Why?
|
| Biological Therapy | 1 | 2015 | 20 | 0.480 |
Why?
|
| Patient Compliance | 1 | 2018 | 469 | 0.470 |
Why?
|
| Remission Induction | 3 | 2020 | 299 | 0.470 |
Why?
|
| Dextran Sulfate | 4 | 2019 | 48 | 0.460 |
Why?
|
| Antimetabolites | 1 | 2014 | 33 | 0.450 |
Why?
|
| Environment | 2 | 2016 | 144 | 0.450 |
Why?
|
| Dysbiosis | 3 | 2022 | 122 | 0.450 |
Why?
|
| Toll-Like Receptor 2 | 2 | 2011 | 59 | 0.440 |
Why?
|
| Hospital Costs | 1 | 2015 | 178 | 0.440 |
Why?
|
| Stress, Psychological | 1 | 2018 | 541 | 0.430 |
Why?
|
| Anus Diseases | 1 | 2013 | 12 | 0.430 |
Why?
|
| Severity of Illness Index | 10 | 2021 | 2883 | 0.430 |
Why?
|
| Allopurinol | 1 | 2014 | 71 | 0.430 |
Why?
|
| Mast Cells | 1 | 2013 | 74 | 0.420 |
Why?
|
| Parents | 1 | 2020 | 1012 | 0.420 |
Why?
|
| Immunosuppressive Agents | 2 | 2014 | 647 | 0.420 |
Why?
|
| Enteritis | 1 | 2013 | 54 | 0.420 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 3 | 2018 | 1015 | 0.420 |
Why?
|
| Biopsy | 6 | 2019 | 1239 | 0.420 |
Why?
|
| Cellulose | 1 | 2013 | 19 | 0.420 |
Why?
|
| Postoperative Complications | 4 | 2019 | 3065 | 0.410 |
Why?
|
| CpG Islands | 4 | 2017 | 323 | 0.410 |
Why?
|
| Eosinophils | 1 | 2013 | 120 | 0.410 |
Why?
|
| Heart Transplantation | 1 | 2019 | 853 | 0.410 |
Why?
|
| Nutritional Physiological Phenomena | 1 | 2013 | 93 | 0.410 |
Why?
|
| Treatment Outcome | 13 | 2023 | 12289 | 0.410 |
Why?
|
| Genetic Diseases, Inborn | 2 | 2007 | 443 | 0.410 |
Why?
|
| Biota | 1 | 2012 | 6 | 0.400 |
Why?
|
| Eosinophilia | 1 | 2013 | 101 | 0.400 |
Why?
|
| Th17 Cells | 1 | 2013 | 90 | 0.390 |
Why?
|
| Enterococcus | 1 | 2012 | 29 | 0.380 |
Why?
|
| Micronutrients | 1 | 2012 | 69 | 0.380 |
Why?
|
| Animals | 18 | 2022 | 34046 | 0.380 |
Why?
|
| Smad4 Protein | 1 | 2012 | 55 | 0.380 |
Why?
|
| Limb Deformities, Congenital | 4 | 2006 | 106 | 0.380 |
Why?
|
| Bacterial Physiological Phenomena | 1 | 2011 | 16 | 0.370 |
Why?
|
| Mice | 12 | 2022 | 17625 | 0.360 |
Why?
|
| Appendix | 1 | 2011 | 15 | 0.360 |
Why?
|
| Genetic Drift | 1 | 2010 | 22 | 0.360 |
Why?
|
| Duodenum | 1 | 2011 | 99 | 0.360 |
Why?
|
| Inflammation | 3 | 2019 | 1428 | 0.360 |
Why?
|
| Host-Pathogen Interactions | 1 | 2013 | 253 | 0.350 |
Why?
|
| Immunity, Mucosal | 3 | 2017 | 87 | 0.350 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2012 | 325 | 0.350 |
Why?
|
| Maternal Nutritional Physiological Phenomena | 1 | 2011 | 48 | 0.350 |
Why?
|
| Intestinal Diseases | 1 | 2011 | 83 | 0.350 |
Why?
|
| Endoscopy | 3 | 2024 | 280 | 0.350 |
Why?
|
| Disease Progression | 8 | 2020 | 2044 | 0.340 |
Why?
|
| Genetics, Medical | 2 | 2010 | 118 | 0.340 |
Why?
|
| Haploinsufficiency | 1 | 2012 | 258 | 0.340 |
Why?
|
| Retrospective Studies | 13 | 2023 | 16293 | 0.340 |
Why?
|
| Environmental Exposure | 3 | 2018 | 221 | 0.340 |
Why?
|
| Interferon Regulatory Factors | 1 | 2010 | 37 | 0.340 |
Why?
|
| Darier Disease | 2 | 2007 | 4 | 0.340 |
Why?
|
| Mammals | 1 | 2011 | 256 | 0.330 |
Why?
|
| Parenteral Nutrition | 1 | 2011 | 194 | 0.330 |
Why?
|
| Pediatric Obesity | 1 | 2015 | 383 | 0.330 |
Why?
|
| C-Reactive Protein | 1 | 2012 | 428 | 0.330 |
Why?
|
| Epidermis | 2 | 2006 | 63 | 0.330 |
Why?
|
| Saccharomyces cerevisiae Proteins | 4 | 2005 | 276 | 0.320 |
Why?
|
| Appendicitis | 1 | 2011 | 126 | 0.320 |
Why?
|
| Aminoglycosides | 2 | 2006 | 45 | 0.320 |
Why?
|
| Cohort Studies | 6 | 2021 | 4779 | 0.310 |
Why?
|
| Codon, Nonsense | 2 | 2006 | 131 | 0.310 |
Why?
|
| Rothmund-Thomson Syndrome | 2 | 2006 | 47 | 0.310 |
Why?
|
| Chromosomes, Human, Pair 13 | 1 | 2008 | 49 | 0.310 |
Why?
|
| Cell Adhesion Molecules | 1 | 2010 | 221 | 0.310 |
Why?
|
| Aortitis | 1 | 2008 | 6 | 0.300 |
Why?
|
| Gastric Outlet Obstruction | 1 | 2008 | 15 | 0.300 |
Why?
|
| Probability | 2 | 2006 | 323 | 0.300 |
Why?
|
| Vacuoles | 3 | 2003 | 24 | 0.290 |
Why?
|
| Case-Control Studies | 9 | 2019 | 3266 | 0.290 |
Why?
|
| Fingers | 2 | 2007 | 65 | 0.290 |
Why?
|
| Colonoscopy | 3 | 2021 | 236 | 0.290 |
Why?
|
| Chromosomes, Human, Pair 15 | 1 | 2008 | 160 | 0.290 |
Why?
|
| Hospitalization | 2 | 2018 | 1770 | 0.290 |
Why?
|
| Antigens, Neoplasm | 1 | 2010 | 383 | 0.280 |
Why?
|
| Wound Healing | 2 | 2021 | 436 | 0.280 |
Why?
|
| Risk Factors | 8 | 2020 | 10248 | 0.280 |
Why?
|
| Esophagitis | 1 | 2007 | 40 | 0.280 |
Why?
|
| Sequence Analysis, DNA | 7 | 2019 | 1748 | 0.280 |
Why?
|
| Adult | 17 | 2023 | 29359 | 0.280 |
Why?
|
| Translocation, Genetic | 2 | 2008 | 357 | 0.270 |
Why?
|
| Steroids | 1 | 2008 | 202 | 0.270 |
Why?
|
| Promoter Regions, Genetic | 2 | 2010 | 1328 | 0.270 |
Why?
|
| Opportunistic Infections | 1 | 2007 | 77 | 0.270 |
Why?
|
| Gene Duplication | 1 | 2008 | 361 | 0.270 |
Why?
|
| Adalimumab | 3 | 2022 | 26 | 0.260 |
Why?
|
| Age Factors | 5 | 2019 | 2808 | 0.260 |
Why?
|
| Adenosine Triphosphatases | 3 | 2006 | 200 | 0.260 |
Why?
|
| Molecular Chaperones | 3 | 2005 | 167 | 0.260 |
Why?
|
| Young Adult | 9 | 2020 | 9000 | 0.260 |
Why?
|
| Mutation | 14 | 2023 | 5816 | 0.260 |
Why?
|
| Diagnosis, Differential | 4 | 2019 | 1881 | 0.260 |
Why?
|
| Esophagoscopy | 1 | 2007 | 156 | 0.260 |
Why?
|
| Colon, Transverse | 2 | 2018 | 6 | 0.260 |
Why?
|
| IgA Deficiency | 1 | 2005 | 5 | 0.260 |
Why?
|
| Phase Transition | 1 | 2005 | 17 | 0.250 |
Why?
|
| Ring Chromosomes | 1 | 2005 | 12 | 0.250 |
Why?
|
| Gels | 1 | 2005 | 69 | 0.250 |
Why?
|
| Chromosomes, Human, Pair 18 | 1 | 2005 | 62 | 0.250 |
Why?
|
| DNA Helicases | 2 | 2006 | 231 | 0.240 |
Why?
|
| Chromosome Deletion | 1 | 2008 | 647 | 0.240 |
Why?
|
| Biomarkers, Tumor | 1 | 2013 | 1476 | 0.240 |
Why?
|
| Gastroenteritis | 1 | 2008 | 348 | 0.240 |
Why?
|
| Muscle Hypotonia | 1 | 2005 | 187 | 0.230 |
Why?
|
| Infant | 11 | 2025 | 12465 | 0.230 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2007 | 190 | 0.230 |
Why?
|
| Follow-Up Studies | 8 | 2020 | 5129 | 0.230 |
Why?
|
| Bacterial Typing Techniques | 2 | 2016 | 102 | 0.220 |
Why?
|
| Erythema Infectiosum | 1 | 2003 | 8 | 0.220 |
Why?
|
| Spherocytosis, Hereditary | 1 | 2003 | 8 | 0.220 |
Why?
|
| Receptors, Interleukin | 3 | 2016 | 33 | 0.220 |
Why?
|
| Parvovirus B19, Human | 1 | 2003 | 30 | 0.220 |
Why?
|
| Texas | 3 | 2020 | 3578 | 0.220 |
Why?
|
| Prognosis | 8 | 2020 | 4609 | 0.220 |
Why?
|
| Ileum | 3 | 2018 | 132 | 0.220 |
Why?
|
| Syndrome | 9 | 2017 | 1119 | 0.220 |
Why?
|
| Craniosynostoses | 1 | 2006 | 133 | 0.220 |
Why?
|
| Receptors, Prostaglandin E, EP4 Subtype | 2 | 2021 | 6 | 0.220 |
Why?
|
| Chromosome Disorders | 1 | 2005 | 311 | 0.210 |
Why?
|
| Necrosis | 1 | 2024 | 208 | 0.210 |
Why?
|
| Twins, Monozygotic | 3 | 2013 | 117 | 0.210 |
Why?
|
| Anemia, Aplastic | 1 | 2003 | 59 | 0.210 |
Why?
|
| Prospective Studies | 6 | 2022 | 6118 | 0.210 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2024 | 680 | 0.210 |
Why?
|
| Joint Diseases | 1 | 2023 | 33 | 0.210 |
Why?
|
| Protein Biosynthesis | 1 | 2006 | 664 | 0.210 |
Why?
|
| Quantitative Trait Loci | 3 | 2022 | 288 | 0.210 |
Why?
|
| Models, Biological | 4 | 2011 | 1454 | 0.200 |
Why?
|
| Rectal Prolapse | 1 | 2021 | 5 | 0.190 |
Why?
|
| Arylsulfotransferase | 1 | 2021 | 7 | 0.190 |
Why?
|
| Seroconversion | 1 | 2021 | 14 | 0.190 |
Why?
|
| Counseling | 1 | 2023 | 216 | 0.190 |
Why?
|
| Interferon-Induced Helicase, IFIH1 | 1 | 2021 | 13 | 0.190 |
Why?
|
| Adenomatous Polyposis Coli | 1 | 2021 | 42 | 0.190 |
Why?
|
| Chronic Disease | 2 | 2022 | 1179 | 0.190 |
Why?
|
| Acute Disease | 2 | 2016 | 1107 | 0.190 |
Why?
|
| Carbohydrate Metabolism | 2 | 2020 | 56 | 0.180 |
Why?
|
| Calbindin 2 | 1 | 2021 | 17 | 0.180 |
Why?
|
| United States | 5 | 2022 | 10868 | 0.180 |
Why?
|
| Morbidity | 1 | 2022 | 246 | 0.180 |
Why?
|
| Cytomegalovirus | 1 | 2022 | 270 | 0.180 |
Why?
|
| Nod2 Signaling Adaptor Protein | 2 | 2023 | 22 | 0.180 |
Why?
|
| Single-Blind Method | 1 | 2021 | 231 | 0.170 |
Why?
|
| Loss of Function Mutation | 1 | 2021 | 149 | 0.170 |
Why?
|
| Minority Groups | 1 | 2022 | 247 | 0.170 |
Why?
|
| Disease Models, Animal | 2 | 2022 | 4344 | 0.170 |
Why?
|
| Population Health | 1 | 2020 | 37 | 0.170 |
Why?
|
| Family Characteristics | 1 | 2020 | 72 | 0.170 |
Why?
|
| Odds Ratio | 2 | 2014 | 1252 | 0.170 |
Why?
|
| Clostridiales | 1 | 2019 | 9 | 0.160 |
Why?
|
| Anemia, Sickle Cell | 1 | 2003 | 338 | 0.160 |
Why?
|
| Income | 1 | 2020 | 133 | 0.160 |
Why?
|
| Incidence | 3 | 2022 | 3135 | 0.160 |
Why?
|
| Aging | 2 | 2018 | 1165 | 0.160 |
Why?
|
| Gene Expression Profiling | 4 | 2018 | 1701 | 0.160 |
Why?
|
| Drug Administration Routes | 1 | 2019 | 32 | 0.160 |
Why?
|
| Infant, Newborn | 7 | 2022 | 8189 | 0.160 |
Why?
|
| Pyloric Antrum | 1 | 2019 | 64 | 0.160 |
Why?
|
| alpha-Defensins | 1 | 2018 | 7 | 0.160 |
Why?
|
| Colon, Ascending | 1 | 2018 | 8 | 0.160 |
Why?
|
| Peyer's Patches | 1 | 2018 | 21 | 0.160 |
Why?
|
| Genotype | 7 | 2022 | 2556 | 0.150 |
Why?
|
| Mendelian Randomization Analysis | 1 | 2019 | 84 | 0.150 |
Why?
|
| Patient Care | 1 | 2019 | 99 | 0.150 |
Why?
|
| Regression Analysis | 1 | 2020 | 777 | 0.150 |
Why?
|
| Hepatocyte Nuclear Factor 4 | 1 | 2018 | 19 | 0.150 |
Why?
|
| Pediatrics | 2 | 2019 | 1159 | 0.150 |
Why?
|
| Autism Spectrum Disorder | 1 | 2023 | 384 | 0.150 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2020 | 394 | 0.150 |
Why?
|
| Immunologic Factors | 1 | 2019 | 174 | 0.150 |
Why?
|
| Tobacco Smoke Pollution | 1 | 2018 | 76 | 0.140 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2011 | 1284 | 0.140 |
Why?
|
| Referral and Consultation | 1 | 2021 | 542 | 0.140 |
Why?
|
| Endoscopy, Gastrointestinal | 1 | 2019 | 241 | 0.140 |
Why?
|
| Optical Tweezers | 1 | 2017 | 8 | 0.140 |
Why?
|
| Double-Blind Method | 1 | 2021 | 1630 | 0.140 |
Why?
|
| Mechanical Phenomena | 1 | 2017 | 16 | 0.140 |
Why?
|
| Oncogene Proteins | 2 | 2008 | 136 | 0.140 |
Why?
|
| In Situ Hybridization, Fluorescence | 3 | 2008 | 762 | 0.140 |
Why?
|
| Breast Feeding | 1 | 2018 | 218 | 0.140 |
Why?
|
| Gastric Bypass | 1 | 2018 | 70 | 0.140 |
Why?
|
| Stochastic Processes | 2 | 2007 | 34 | 0.140 |
Why?
|
| Nanotechnology | 1 | 2017 | 49 | 0.130 |
Why?
|
| Gene-Environment Interaction | 1 | 2017 | 121 | 0.130 |
Why?
|
| HLA-DRB1 Chains | 1 | 2016 | 38 | 0.130 |
Why?
|
| Polyps | 1 | 2017 | 45 | 0.130 |
Why?
|
| Monocytes | 1 | 2019 | 351 | 0.130 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2020 | 380 | 0.130 |
Why?
|
| Jejunal Diseases | 1 | 2016 | 15 | 0.130 |
Why?
|
| T-Lymphocytes | 2 | 2020 | 1708 | 0.130 |
Why?
|
| Ubiquitin Thiolesterase | 1 | 2016 | 58 | 0.130 |
Why?
|
| Cell Adhesion Molecules, Neuronal | 1 | 2016 | 77 | 0.130 |
Why?
|
| Sodium-Hydrogen Exchanger 3 | 1 | 2016 | 12 | 0.130 |
Why?
|
| Colonic Diseases | 1 | 2016 | 37 | 0.130 |
Why?
|
| Interleukins | 1 | 2017 | 120 | 0.130 |
Why?
|
| Fistula | 1 | 2016 | 49 | 0.130 |
Why?
|
| Sodium-Hydrogen Exchangers | 1 | 2016 | 40 | 0.130 |
Why?
|
| Biodiversity | 1 | 2016 | 64 | 0.130 |
Why?
|
| Neurons | 1 | 2005 | 1957 | 0.120 |
Why?
|
| Healthy Volunteers | 1 | 2016 | 131 | 0.120 |
Why?
|
| Neoplasms | 2 | 2022 | 2765 | 0.120 |
Why?
|
| Computational Biology | 2 | 2011 | 808 | 0.120 |
Why?
|
| RNA, Long Noncoding | 1 | 2018 | 210 | 0.120 |
Why?
|
| Digestive System Surgical Procedures | 1 | 2016 | 84 | 0.120 |
Why?
|
| Cough | 1 | 2016 | 87 | 0.120 |
Why?
|
| Antibodies, Viral | 1 | 2021 | 1151 | 0.120 |
Why?
|
| Genetic Loci | 3 | 2015 | 338 | 0.120 |
Why?
|
| Survival Analysis | 1 | 2019 | 1491 | 0.120 |
Why?
|
| Salmonella | 1 | 2015 | 28 | 0.120 |
Why?
|
| Microcephaly | 3 | 2008 | 330 | 0.120 |
Why?
|
| Pharmacogenetics | 2 | 2006 | 184 | 0.120 |
Why?
|
| Spleen | 1 | 2016 | 281 | 0.120 |
Why?
|
| DNA Mutational Analysis | 5 | 2014 | 793 | 0.120 |
Why?
|
| Salmonella Infections | 1 | 2015 | 31 | 0.120 |
Why?
|
| Stomach | 1 | 2017 | 271 | 0.120 |
Why?
|
| Viruses | 1 | 2016 | 124 | 0.120 |
Why?
|
| Guanine Nucleotides | 1 | 2014 | 15 | 0.120 |
Why?
|
| Receptors, Lipoprotein | 1 | 2014 | 11 | 0.120 |
Why?
|
| Pancreatitis | 1 | 2016 | 128 | 0.120 |
Why?
|
| Thionucleotides | 1 | 2014 | 21 | 0.120 |
Why?
|
| Tuberculosis | 1 | 2020 | 521 | 0.110 |
Why?
|
| Transfusion Reaction | 1 | 2014 | 42 | 0.110 |
Why?
|
| North America | 3 | 2019 | 239 | 0.110 |
Why?
|
| Phylogeny | 1 | 2016 | 694 | 0.110 |
Why?
|
| Registries | 1 | 2020 | 1421 | 0.110 |
Why?
|
| Papilloma | 1 | 2013 | 26 | 0.110 |
Why?
|
| Induction Chemotherapy | 1 | 2013 | 43 | 0.110 |
Why?
|
| PPAR alpha | 1 | 2013 | 51 | 0.110 |
Why?
|
| Cell Count | 1 | 2013 | 252 | 0.110 |
Why?
|
| Transplantation, Homologous | 1 | 2015 | 662 | 0.110 |
Why?
|
| Pedigree | 4 | 2011 | 1605 | 0.110 |
Why?
|
| Hypertriglyceridemia | 1 | 2014 | 102 | 0.100 |
Why?
|
| Protein Modification, Translational | 1 | 2012 | 2 | 0.100 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2019 | 728 | 0.100 |
Why?
|
| Genome | 1 | 2016 | 469 | 0.100 |
Why?
|
| Mice, Knockout | 2 | 2011 | 3727 | 0.100 |
Why?
|
| Methylation | 1 | 2013 | 222 | 0.100 |
Why?
|
| Smoking | 1 | 2018 | 1044 | 0.100 |
Why?
|
| Pandemics | 1 | 2020 | 1096 | 0.100 |
Why?
|
| Ribosome Subunits, Small | 1 | 2012 | 3 | 0.100 |
Why?
|
| Dietary Fiber | 1 | 2013 | 74 | 0.100 |
Why?
|
| Energy Metabolism | 1 | 2018 | 774 | 0.100 |
Why?
|
| Nuclear Proteins | 3 | 2008 | 1265 | 0.100 |
Why?
|
| Nerve Growth Factors | 1 | 2013 | 71 | 0.100 |
Why?
|
| Potassium Channels, Tandem Pore Domain | 1 | 2013 | 30 | 0.100 |
Why?
|
| Risk Assessment | 5 | 2019 | 3431 | 0.100 |
Why?
|
| RNA, Messenger | 4 | 2018 | 2815 | 0.100 |
Why?
|
| Genes, Bacterial | 1 | 2013 | 209 | 0.100 |
Why?
|
| Biomarkers | 2 | 2018 | 3049 | 0.100 |
Why?
|
| Pregnancy | 3 | 2018 | 7179 | 0.100 |
Why?
|
| Transcription, Genetic | 1 | 2017 | 1696 | 0.100 |
Why?
|
| Disease-Free Survival | 1 | 2014 | 865 | 0.100 |
Why?
|
| Practice Guidelines as Topic | 1 | 2019 | 1264 | 0.090 |
Why?
|
| Aged | 5 | 2021 | 19537 | 0.090 |
Why?
|
| Repressor Proteins | 1 | 2016 | 816 | 0.090 |
Why?
|
| Diseases in Twins | 1 | 2012 | 94 | 0.090 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2013 | 243 | 0.090 |
Why?
|
| Biomedical Research | 1 | 2017 | 516 | 0.090 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2021 | 3549 | 0.090 |
Why?
|
| Stomach Neoplasms | 1 | 2017 | 545 | 0.090 |
Why?
|
| Betaine | 1 | 2011 | 22 | 0.090 |
Why?
|
| Golgi Apparatus | 2 | 2003 | 93 | 0.090 |
Why?
|
| Species Specificity | 1 | 2012 | 549 | 0.090 |
Why?
|
| Symbiosis | 1 | 2011 | 64 | 0.090 |
Why?
|
| Vitamin B 12 | 1 | 2011 | 55 | 0.090 |
Why?
|
| Anorexia Nervosa | 1 | 2010 | 24 | 0.090 |
Why?
|
| Choline | 1 | 2011 | 54 | 0.090 |
Why?
|
| DNA, Bacterial | 1 | 2012 | 477 | 0.090 |
Why?
|
| Drug Therapy, Combination | 1 | 2014 | 1162 | 0.090 |
Why?
|
| DNA Primers | 2 | 2010 | 657 | 0.090 |
Why?
|
| Proteins | 1 | 2016 | 1036 | 0.090 |
Why?
|
| Colonic Neoplasms | 1 | 2013 | 249 | 0.090 |
Why?
|
| Epithelial Cell Adhesion Molecule | 1 | 2010 | 4 | 0.090 |
Why?
|
| Neuropeptides | 1 | 2010 | 113 | 0.080 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2014 | 1104 | 0.080 |
Why?
|
| Animals, Newborn | 1 | 2013 | 1006 | 0.080 |
Why?
|
| INDEL Mutation | 1 | 2010 | 87 | 0.080 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2008 | 2089 | 0.080 |
Why?
|
| Adaptation, Physiological | 1 | 2011 | 270 | 0.080 |
Why?
|
| Whole Genome Sequencing | 2 | 2021 | 277 | 0.080 |
Why?
|
| Exome | 1 | 2014 | 1033 | 0.080 |
Why?
|
| Intellectual Disability | 2 | 2008 | 1054 | 0.080 |
Why?
|
| Hungary | 2 | 2006 | 7 | 0.080 |
Why?
|
| Microarray Analysis | 1 | 2010 | 229 | 0.080 |
Why?
|
| Constriction, Pathologic | 2 | 2021 | 242 | 0.080 |
Why?
|
| Histones | 1 | 2012 | 526 | 0.080 |
Why?
|
| Transforming Growth Factor beta | 1 | 2012 | 457 | 0.080 |
Why?
|
| Hospitals, Pediatric | 1 | 2014 | 769 | 0.080 |
Why?
|
| Logistic Models | 1 | 2014 | 1799 | 0.080 |
Why?
|
| Time Factors | 3 | 2018 | 6283 | 0.080 |
Why?
|
| Thymine | 2 | 2005 | 15 | 0.080 |
Why?
|
| RecQ Helicases | 2 | 2006 | 62 | 0.080 |
Why?
|
| Reference Values | 2 | 2015 | 711 | 0.080 |
Why?
|
| Genetic Testing | 2 | 2021 | 997 | 0.080 |
Why?
|
| Intestinal Atresia | 1 | 2008 | 19 | 0.080 |
Why?
|
| Cytosine | 2 | 2005 | 56 | 0.080 |
Why?
|
| Folic Acid | 1 | 2011 | 292 | 0.080 |
Why?
|
| Lung | 1 | 2016 | 1487 | 0.070 |
Why?
|
| Mucous Membrane | 1 | 2008 | 88 | 0.070 |
Why?
|
| Methylprednisolone | 1 | 2008 | 91 | 0.070 |
Why?
|
| Telangiectasia, Hereditary Hemorrhagic | 1 | 2007 | 6 | 0.070 |
Why?
|
| Thyrotoxicosis | 1 | 2007 | 5 | 0.070 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2010 | 555 | 0.070 |
Why?
|
| Siblings | 1 | 2008 | 197 | 0.070 |
Why?
|
| Magnesium | 2 | 2005 | 121 | 0.070 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2008 | 161 | 0.070 |
Why?
|
| Metabolic Syndrome | 1 | 2011 | 338 | 0.070 |
Why?
|
| Short Rib-Polydactyly Syndrome | 1 | 2006 | 2 | 0.070 |
Why?
|
| Metabolomics | 1 | 2010 | 421 | 0.070 |
Why?
|
| Epistasis, Genetic | 1 | 2007 | 93 | 0.070 |
Why?
|
| Sarcoplasmic Reticulum Calcium-Transporting ATPases | 1 | 2006 | 37 | 0.070 |
Why?
|
| Colorectal Neoplasms | 1 | 2013 | 566 | 0.070 |
Why?
|
| Homeostasis | 2 | 2003 | 685 | 0.070 |
Why?
|
| Cholestanol | 1 | 2006 | 3 | 0.070 |
Why?
|
| Lithium | 1 | 2006 | 64 | 0.070 |
Why?
|
| Carcinoma, Skin Appendage | 1 | 2006 | 2 | 0.070 |
Why?
|
| Huntington Disease | 1 | 2008 | 143 | 0.070 |
Why?
|
| Xanthomatosis, Cerebrotendinous | 1 | 2006 | 4 | 0.070 |
Why?
|
| Thyroidectomy | 1 | 2007 | 100 | 0.070 |
Why?
|
| Infusions, Intravenous | 1 | 2008 | 547 | 0.070 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2012 | 868 | 0.070 |
Why?
|
| Genetic Counseling | 1 | 2008 | 220 | 0.070 |
Why?
|
| Body Weight | 1 | 2010 | 995 | 0.070 |
Why?
|
| Base Sequence | 4 | 2017 | 3089 | 0.070 |
Why?
|
| Obesity | 1 | 2018 | 2262 | 0.070 |
Why?
|
| Arginine | 2 | 2005 | 331 | 0.060 |
Why?
|
| Chylothorax | 1 | 2006 | 27 | 0.060 |
Why?
|
| Control Groups | 1 | 2005 | 12 | 0.060 |
Why?
|
| Gene Regulatory Networks | 2 | 2019 | 351 | 0.060 |
Why?
|
| Genes, sry | 1 | 2005 | 1 | 0.060 |
Why?
|
| Duodenal Obstruction | 1 | 2005 | 12 | 0.060 |
Why?
|
| HMG-Box Domains | 1 | 2005 | 5 | 0.060 |
Why?
|
| Gonadal Dysgenesis, 46,XY | 1 | 2005 | 16 | 0.060 |
Why?
|
| Cytosol | 3 | 2004 | 161 | 0.060 |
Why?
|
| Electrodes | 1 | 2005 | 98 | 0.060 |
Why?
|
| Gene Expression Regulation, Fungal | 2 | 2003 | 54 | 0.060 |
Why?
|
| Esophagus | 1 | 2007 | 216 | 0.060 |
Why?
|
| Palate | 1 | 2005 | 12 | 0.060 |
Why?
|
| Severe Combined Immunodeficiency | 1 | 2006 | 106 | 0.060 |
Why?
|
| Esophageal Atresia | 1 | 2005 | 51 | 0.060 |
Why?
|
| Asthma | 1 | 2013 | 749 | 0.060 |
Why?
|
| Connexin 43 | 1 | 2005 | 30 | 0.060 |
Why?
|
| alpha-Thalassemia | 1 | 2005 | 13 | 0.060 |
Why?
|
| Joint Dislocations | 1 | 2005 | 23 | 0.060 |
Why?
|
| Sex Chromosome Aberrations | 1 | 2005 | 56 | 0.060 |
Why?
|
| Chromosomes, Human, Y | 1 | 2005 | 46 | 0.060 |
Why?
|
| Connexins | 1 | 2005 | 60 | 0.060 |
Why?
|
| Electric Stimulation | 1 | 2005 | 321 | 0.060 |
Why?
|
| Spine | 1 | 2005 | 143 | 0.060 |
Why?
|
| Frameshift Mutation | 1 | 2005 | 180 | 0.060 |
Why?
|
| Deafness | 1 | 2005 | 83 | 0.060 |
Why?
|
| Ectodermal Dysplasia | 1 | 2005 | 45 | 0.060 |
Why?
|
| Up-Regulation | 2 | 2018 | 862 | 0.060 |
Why?
|
| Propensity Score | 2 | 2017 | 215 | 0.060 |
Why?
|
| DNA, Mitochondrial | 1 | 2005 | 210 | 0.060 |
Why?
|
| Cataract | 1 | 2006 | 222 | 0.060 |
Why?
|
| Point Mutation | 1 | 2005 | 346 | 0.060 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2006 | 464 | 0.050 |
Why?
|
| Mutation, Missense | 2 | 2005 | 875 | 0.050 |
Why?
|
| Sex Factors | 2 | 2019 | 1277 | 0.050 |
Why?
|
| Growth Disorders | 1 | 2005 | 208 | 0.050 |
Why?
|
| Drug Administration Schedule | 2 | 2016 | 722 | 0.050 |
Why?
|
| Bone and Bones | 1 | 2005 | 265 | 0.050 |
Why?
|
| Blotting, Northern | 1 | 2003 | 259 | 0.050 |
Why?
|
| Genomics | 1 | 2010 | 1492 | 0.050 |
Why?
|
| Skin | 1 | 2006 | 517 | 0.050 |
Why?
|
| Rats | 2 | 2006 | 3676 | 0.050 |
Why?
|
| Middle Aged | 5 | 2015 | 26601 | 0.050 |
Why?
|
| Fungal Proteins | 2 | 1999 | 134 | 0.050 |
Why?
|
| Liver | 1 | 2009 | 1735 | 0.050 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2003 | 256 | 0.050 |
Why?
|
| Infant, Premature | 1 | 2007 | 812 | 0.050 |
Why?
|
| Metronidazole | 1 | 2022 | 154 | 0.050 |
Why?
|
| Alleles | 2 | 2017 | 1614 | 0.050 |
Why?
|
| Transcriptome | 2 | 2019 | 950 | 0.050 |
Why?
|
| Italy | 1 | 2021 | 97 | 0.050 |
Why?
|
| Cell Adhesion | 1 | 2021 | 324 | 0.040 |
Why?
|
| Breast Neoplasms | 1 | 2013 | 2498 | 0.040 |
Why?
|
| Glucose | 1 | 2004 | 879 | 0.040 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 1999 | 68 | 0.040 |
Why?
|
| Ion Exchange | 1 | 1999 | 5 | 0.040 |
Why?
|
| Signal Transduction | 1 | 2012 | 4504 | 0.040 |
Why?
|
| Antiporters | 1 | 1999 | 32 | 0.040 |
Why?
|
| Radiography | 2 | 2016 | 821 | 0.040 |
Why?
|
| Macrolides | 1 | 1999 | 29 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2003 | 1689 | 0.040 |
Why?
|
| Skin Neoplasms | 1 | 2006 | 808 | 0.040 |
Why?
|
| Gene Frequency | 1 | 2021 | 721 | 0.040 |
Why?
|
| Protein Precursors | 1 | 1999 | 153 | 0.040 |
Why?
|
| Cation Transport Proteins | 1 | 1999 | 93 | 0.040 |
Why?
|
| Puberty | 1 | 2018 | 94 | 0.040 |
Why?
|
| Th1 Cells | 1 | 2018 | 153 | 0.040 |
Why?
|
| Europe | 1 | 2019 | 352 | 0.040 |
Why?
|
| Caco-2 Cells | 1 | 2018 | 95 | 0.040 |
Why?
|
| Calcium-Binding Proteins | 1 | 1999 | 325 | 0.040 |
Why?
|
| N-Myc Proto-Oncogene Protein | 2 | 2008 | 55 | 0.040 |
Why?
|
| Glycoproteins | 1 | 1999 | 368 | 0.030 |
Why?
|
| Datasets as Topic | 1 | 2017 | 89 | 0.030 |
Why?
|
| Observational Studies as Topic | 1 | 2017 | 87 | 0.030 |
Why?
|
| Interleukin-23 | 1 | 2017 | 12 | 0.030 |
Why?
|
| Toes | 2 | 2008 | 28 | 0.030 |
Why?
|
| Interleukin-5 | 1 | 2017 | 43 | 0.030 |
Why?
|
| Interleukin-13 Receptor alpha2 Subunit | 1 | 2017 | 20 | 0.030 |
Why?
|
| Interleukin-12 Subunit p40 | 1 | 2016 | 14 | 0.030 |
Why?
|
| Sorting Nexins | 1 | 2016 | 8 | 0.030 |
Why?
|
| Receptors, CXCR6 | 1 | 2016 | 14 | 0.030 |
Why?
|
| HLA-DQ alpha-Chains | 1 | 2016 | 17 | 0.030 |
Why?
|
| Tenascin | 1 | 2016 | 31 | 0.030 |
Why?
|
| Receptors, Chemokine | 1 | 2016 | 44 | 0.030 |
Why?
|
| Risk | 1 | 2018 | 754 | 0.030 |
Why?
|
| Interleukin-13 | 1 | 2017 | 97 | 0.030 |
Why?
|
| Adenylyl Cyclases | 1 | 2016 | 83 | 0.030 |
Why?
|
| Genotyping Techniques | 1 | 2016 | 103 | 0.030 |
Why?
|
| KCNQ2 Potassium Channel | 1 | 2016 | 41 | 0.030 |
Why?
|
| Rectum | 1 | 2017 | 100 | 0.030 |
Why?
|
| Roma | 2 | 2006 | 4 | 0.030 |
Why?
|
| Peptides | 1 | 1999 | 794 | 0.030 |
Why?
|
| GPI-Linked Proteins | 1 | 2016 | 98 | 0.030 |
Why?
|
| Interleukin-17 | 1 | 2017 | 119 | 0.030 |
Why?
|
| Gastroscopy | 1 | 2016 | 100 | 0.030 |
Why?
|
| Area Under Curve | 1 | 2017 | 319 | 0.030 |
Why?
|
| Receptors, Virus | 1 | 2016 | 107 | 0.030 |
Why?
|
| Biomechanical Phenomena | 1 | 2017 | 225 | 0.030 |
Why?
|
| Cholangiopancreatography, Endoscopic Retrograde | 1 | 2016 | 77 | 0.030 |
Why?
|
| Nausea | 1 | 2016 | 83 | 0.030 |
Why?
|
| Intestinal Obstruction | 1 | 2017 | 94 | 0.030 |
Why?
|
| Bile Acids and Salts | 1 | 2018 | 242 | 0.030 |
Why?
|
| Down-Regulation | 1 | 2018 | 697 | 0.030 |
Why?
|
| Vomiting | 1 | 2016 | 105 | 0.030 |
Why?
|
| ROC Curve | 1 | 2017 | 566 | 0.030 |
Why?
|
| Societies, Medical | 1 | 2019 | 690 | 0.030 |
Why?
|
| Fatigue | 1 | 2016 | 185 | 0.030 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2017 | 307 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2018 | 1320 | 0.030 |
Why?
|
| Models, Genetic | 1 | 2017 | 759 | 0.030 |
Why?
|
| Software | 1 | 2019 | 677 | 0.030 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2016 | 503 | 0.030 |
Why?
|
| Matched-Pair Analysis | 1 | 2013 | 27 | 0.030 |
Why?
|
| Azathioprine | 1 | 2013 | 54 | 0.030 |
Why?
|
| Anti-Bacterial Agents | 2 | 2022 | 2427 | 0.030 |
Why?
|
| Reoperation | 1 | 2016 | 831 | 0.030 |
Why?
|
| Combined Modality Therapy | 1 | 2016 | 1228 | 0.020 |
Why?
|
| Algorithms | 1 | 2019 | 1606 | 0.020 |
Why?
|
| Methotrexate | 1 | 2013 | 341 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2017 | 2143 | 0.020 |
Why?
|
| Gambia | 1 | 2010 | 28 | 0.020 |
Why?
|
| Child Development | 1 | 2013 | 267 | 0.020 |
Why?
|
| Orexins | 1 | 2010 | 7 | 0.020 |
Why?
|
| Fertilization | 1 | 2010 | 42 | 0.020 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 3 | 1 | 2010 | 54 | 0.020 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2018 | 1891 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2021 | 6464 | 0.020 |
Why?
|
| Leptin | 1 | 2010 | 216 | 0.020 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2010 | 340 | 0.020 |
Why?
|
| Rural Population | 1 | 2010 | 257 | 0.020 |
Why?
|
| Syndactyly | 1 | 2008 | 24 | 0.020 |
Why?
|
| Nutritional Status | 1 | 2010 | 313 | 0.020 |
Why?
|
| Eating | 1 | 2010 | 374 | 0.020 |
Why?
|
| Digestive System Abnormalities | 1 | 2008 | 36 | 0.020 |
Why?
|
| Genes, Dominant | 1 | 2008 | 245 | 0.020 |
Why?
|
| Family Health | 1 | 2008 | 258 | 0.020 |
Why?
|
| Premenstrual Syndrome | 1 | 2007 | 5 | 0.020 |
Why?
|
| Early Diagnosis | 1 | 2008 | 180 | 0.020 |
Why?
|
| Cholestanols | 1 | 2006 | 2 | 0.020 |
Why?
|
| Founder Effect | 1 | 2006 | 32 | 0.020 |
Why?
|
| Deubiquitinating Enzyme CYLD | 1 | 2006 | 2 | 0.020 |
Why?
|
| Steroid Hydroxylases | 1 | 2006 | 20 | 0.020 |
Why?
|
| Chenodeoxycholic Acid | 1 | 2006 | 13 | 0.020 |
Why?
|
| Cholestanetriol 26-Monooxygenase | 1 | 2006 | 14 | 0.020 |
Why?
|
| Immunoenzyme Techniques | 1 | 2006 | 258 | 0.020 |
Why?
|
| Hypertelorism | 1 | 2006 | 11 | 0.020 |
Why?
|
| Interleukin Receptor Common gamma Subunit | 1 | 2006 | 12 | 0.020 |
Why?
|
| Microtubule Proteins | 1 | 2006 | 27 | 0.020 |
Why?
|
| Karyotyping | 1 | 2006 | 328 | 0.020 |
Why?
|
| Transcription Factors | 2 | 2006 | 2582 | 0.020 |
Why?
|
| Seminal Plasma Proteins | 1 | 2005 | 7 | 0.020 |
Why?
|
| Rats, Wistar | 1 | 2006 | 359 | 0.020 |
Why?
|
| Gonads | 1 | 2005 | 35 | 0.020 |
Why?
|
| Connexin 26 | 1 | 2005 | 14 | 0.020 |
Why?
|
| Fatal Outcome | 1 | 2006 | 355 | 0.020 |
Why?
|
| Patella | 1 | 2005 | 25 | 0.020 |
Why?
|
| Radius | 1 | 2005 | 25 | 0.020 |
Why?
|
| Chromosomes, Human, X | 1 | 2006 | 157 | 0.020 |
Why?
|
| Guanine | 1 | 2005 | 61 | 0.010 |
Why?
|
| Thrombophilia | 1 | 2005 | 43 | 0.010 |
Why?
|
| Hypospadias | 1 | 2006 | 78 | 0.010 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2005 | 108 | 0.010 |
Why?
|
| Proton-Translocating ATPases | 1 | 2004 | 17 | 0.010 |
Why?
|
| Subcellular Fractions | 1 | 2004 | 97 | 0.010 |
Why?
|
| Cleft Lip | 1 | 2006 | 125 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 16 | 1 | 2005 | 150 | 0.010 |
Why?
|
| Cataract Extraction | 1 | 2006 | 216 | 0.010 |
Why?
|
| Glutamine | 1 | 2005 | 215 | 0.010 |
Why?
|
| Amino Acid Substitution | 1 | 2005 | 391 | 0.010 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2006 | 357 | 0.010 |
Why?
|
| Sequence Deletion | 1 | 2005 | 526 | 0.010 |
Why?
|
| Cell Membrane | 1 | 2004 | 460 | 0.010 |
Why?
|
| Kinetics | 1 | 2004 | 1321 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2006 | 3873 | 0.010 |
Why?
|
| Mating Factor | 1 | 1999 | 4 | 0.010 |
Why?
|
| HSP40 Heat-Shock Proteins | 1 | 1999 | 21 | 0.010 |
Why?
|
| DNA | 1 | 2005 | 1595 | 0.010 |
Why?
|
| Genetic Complementation Test | 1 | 1999 | 87 | 0.010 |
Why?
|
| Aequorin | 1 | 1999 | 2 | 0.010 |
Why?
|
| Plasma Membrane Calcium-Transporting ATPases | 1 | 1999 | 16 | 0.010 |
Why?
|
| Metalloendopeptidases | 1 | 1999 | 101 | 0.010 |
Why?
|
| Heat-Shock Proteins | 1 | 1999 | 195 | 0.010 |
Why?
|
| Phosphates | 1 | 1999 | 113 | 0.010 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 1999 | 189 | 0.010 |
Why?
|
| Mutagenesis | 1 | 1999 | 346 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 1999 | 757 | 0.010 |
Why?
|
| Protein Processing, Post-Translational | 1 | 1999 | 355 | 0.010 |
Why?
|
| Epilepsy | 1 | 2005 | 870 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 2005 | 2045 | 0.010 |
Why?
|
| Binding Sites | 1 | 1999 | 1295 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 1999 | 577 | 0.010 |
Why?
|
| Oxidative Stress | 1 | 1999 | 800 | 0.010 |
Why?
|